Literature DB >> 25143866

Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway.

Dustin W Wooten1, Ansel T Hillmer2, Dhanabalan Murali2, Todd E Barnhart3, Joanne P Thio4, Alisha K Bajwa4, Ali A Bonab5, Marc D Normandin5, Mary L Schneider6, Jogeshwar Mukherjee4, Bradley T Christian7.   

Abstract

4-trans-[(18)F]Mefway is a PET radiotracer with high affinity for 5-HT1A receptors. Our preliminary work indicated the positional isomer, 3-[(18)F]mefway, would be suitable for PET imaging of 5-HT1A receptors. We now compare the in vivo behaviour of 3-mefway with 4-mefway to evaluate 3-[(18)F]mefway as a potential 5-HT1A PET radiotracer. Two male rhesus macaques were given bolus injections of both 3- and 4-trans-[(18)F]mefway in separate experiments. 90 minute dynamic PET scans were acquired. TACs were extracted in the mesial temporal lobe (MTL) and caudal anterior cingulate gyrus (cACg). The cerebellum (CB) was used as a reference region. In vivo behavior of the radiotracers in the CB was compared based upon the ratio of normalized PET uptake for 3- and 4-trans-[(18)F]mefway. Specific binding was compared by examining MTL/CB and cACg/CB ratios. The subject-averaged ratio of 3-[(18)F]mefway to 4-trans-[(18)F]mefway in the cerebellum was 0.96 for 60-90 minutes. MTL/CB reached plateaus of ~2.7 and ~6 by 40 minutes and 90 minutes for 3- and 4-trans-[(18)F]mefway, respectively. cACg/CB reached plateaus of ~2.5 and ~6 by 40 minutes and 70 minutes for 3- and 4-trans-[(18)F]mefway, respectively. The short pseudoequilibration times and sufficient uptake of 3-[(18)F]mefway may be useful in studies requiring short scan times. Furthermore, the similar nondisplaceable clearance in the CB to 4-trans-[(18)F]mefway suggests the lower BPND of 3-[(18)F]mefway is due to a lower affinity. The lower affinity of 3-[(18)F]mefway may make it useful for measuring changes in endogenous 5-HT levels, however, this remains to be ascertained.

Entities:  

Keywords:  5-HT1A; PET; mefway; serotonin

Year:  2014        PMID: 25143866      PMCID: PMC4138142     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  13 in total

1.  Performance evaluation of the microPET P4: a PET system dedicated to animal imaging.

Authors:  C Tai; A Chatziioannou; S Siegel; J Young; D Newport; R N Goble; R E Nutt; S R Cherry
Journal:  Phys Med Biol       Date:  2001-07       Impact factor: 3.609

2.  Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging.

Authors:  Yuan-Chuan Tai; Ananya Ruangma; Douglas Rowland; Stefan Siegel; Danny F Newport; Patrick L Chow; Richard Laforest
Journal:  J Nucl Med       Date:  2005-03       Impact factor: 10.057

3.  Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands.

Authors:  C J Endres; R E Carson
Journal:  J Cereb Blood Flow Metab       Date:  1998-11       Impact factor: 6.200

4.  Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.

Authors:  Neil Saigal; Rama Pichika; Balasubramaniam Easwaramoorthy; Daphne Collins; Bradley T Christian; Bingzhi Shi; Tanjore K Narayanan; Steven G Potkin; Jogeshwar Mukherjee
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

5.  In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate.

Authors:  D W Wooten; J D Moraino; A T Hillmer; J W Engle; O J Dejesus; D Murali; T E Barnhart; R J Nickles; R J Davidson; M L Schneider; J Mukherjee; B T Christian
Journal:  Synapse       Date:  2010-12-08       Impact factor: 2.562

6.  Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice.

Authors:  O V Rice; S J Gatley; J Shen; C L Huemmer; R Rogoz; O T DeJesus; N D Volkow; A N Gifford
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

7.  An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate.

Authors:  Dustin Wooten; Ansel Hillmer; Dhanabalan Murali; Todd Barnhart; Mary L Schneider; Jogeshwar Mukherjee; Bradley T Christian
Journal:  Nucl Med Biol       Date:  2011-07-07       Impact factor: 2.408

8.  Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635.

Authors:  E Hirani; J Opacka-Juffry; R Gunn; I Khan; T Sharp; S Hume
Journal:  Synapse       Date:  2000-06-15       Impact factor: 2.562

Review 9.  Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Authors:  Louise M Paterson; Robin J Tyacke; David J Nutt; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

10.  Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635.

Authors:  Lixin Lang; Elaine Jagoda; Ying Ma; Mark B Sassaman; William C Eckelman
Journal:  Bioorg Med Chem       Date:  2006-02-20       Impact factor: 3.641

View more
  2 in total

1.  Synthesis and Evaluation of Mefway Analogs as Ligands for Serotonin 5HT1A Receptors.

Authors:  Joanne P Thio; Christopher Liang; Alisha K Bajwa; Dustin W Wooten; Bradley T Christian; Jogeshwar Mukherjee
Journal:  Med Chem Res       Date:  2015-04       Impact factor: 1.965

2.  P-Glycoprotein, not BCRP, Limits the Brain Uptake of [(18)F]Mefway in Rodent Brain.

Authors:  Jae Yong Choi; Jin Sook Song; Minkyung Lee; Woon-Ki Cho; Jin Chung; Chul Hyoung Lyoo; Chul Hoon Kim; Jiae Park; Kyo Chul Lee; Kyeong Min Kim; Jee Hae Kang; Myung Ae Bae; Young Hoon Ryu
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.